Form 4: Alpha Tau Medical CFO Trades Shares

Alpha Tau Medical Ltd. Chief Financial Officer, Raphi Levy, reports transactions involving ordinary shares, including acquisitions and dispositions.

Summary

• Raphi Levy, Chief Financial Officer of Alpha Tau Medical Ltd., has reported transactions concerning the company's ordinary shares.
• On July 1, 2026, Levy acquired 2,127 ordinary shares at a price of $2.98 per share.
• On the same date, Levy disposed of 2,127 ordinary shares at a price of $13.0189 per share.
• Following these transactions, Levy beneficially owns 90,180 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly negative signal due to the significant disposition of shares by a key executive, despite the profitable nature of the sale.

Positives

• The acquisition of shares by the CFO at a lower price point ($2.98) could indicate a belief in the company's future value.
• The disposition of shares at a significantly higher price ($13.0189) suggests a profitable exit for a portion of the holdings.

Negatives

• The disposition of a substantial number of shares by a key executive could be interpreted negatively by the market, potentially signaling a lack of confidence or a need for personal liquidity.

Risks

• The filing does not explicitly mention any risks associated with these transactions.

Future Outlook

The filing is a statement of changes in beneficial ownership and does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The simultaneous acquisition at a lower price and disposition at a higher price by a CFO can be a complex signal, often requiring further context to fully interpret its implications for investor sentiment.

Stakeholder Impact

• Shareholders may interpret the sale of shares by the CFO as a potential negative signal, possibly leading to short-term price pressure.
• Employees may view the transaction with mixed feelings, depending on their perception of the CFO's confidence in the company's future.

Next Steps

• Monitor future Form 4 filings for any further transactions by Raphi Levy or other insiders.
• Observe market reaction to these reported transactions.

Key Dates

Recommendation

The filing indicates a profitable sale of shares by the CFO, but the disposition of a significant number of shares by a key executive warrants a cautious 'hold' stance until further clarity on the rationale or subsequent transactions emerge.

Keywords

Alpha Tau Medical, DRTS, Form 4, Insider Trading, Shareholder, Securities, CFO, Raphi Levy, Stock Transaction